Interventional Radiology in Liver Cancer. Nakarin Inmutto MD

Size: px
Start display at page:

Download "Interventional Radiology in Liver Cancer. Nakarin Inmutto MD"

Transcription

1 Interventional Radiology in Liver Cancer Nakarin Inmutto MD

2 Liver cancer Primary liver cancer Hepatocellular carcinoma Cholangiocarcinoma Metastasis

3 Interventional Radiologist Diagnosis Imaging US / CT / MRI Tissue diagnosis FNA / Core biopsy Treatment

4 Hepatocellular carcinoma

5 AASLD Every 6 months 1 modality 1 cm No Bx No AFP

6 Hepatoma

7 Hepatoma

8 Hepatoma

9 Arterial phase Portal phase Classic enhancement pattern 24% in tumor size < 1 cm 28% in tumor size 1-2 cm 47% in tumor size > 2 cm

10 MRI

11 Treatment options

12

13

14

15 Barcelona Clinic Liver Cancer (BCLC) Radiologic tumor extent Liver function Patient s performance status Best chance of predicting patient survival

16 ECOG : PS

17 Child-Pugh Score

18 Interventional Radiologits

19 Local ablation

20 * *

21 Ethanol Dehydration Coagulation necrosis Small vessel thrombosis Low cost /Treat in critical site Multiple sessions / Local recurrent

22 PEI

23 PEI

24 RFA Radiofrequency ablation Localised treatment Heat the tumor tissue Temperatures exceeds 60c Imaging guidance: US / CT

25 RFA

26 RFA Alternating current of radio frequency waves Changes in the direction of ions Ionic agitation and frictional heating Coagulative necrosis

27

28

29

30

31 Meta-analysis: RFa VS Sx No difference in 1-y and 3-y recurrences

32 TACE

33 TACE

34 TACE TransArterial ChemoEmbolization TOCE TransArterial Oily Chemoembolization Drug + Oil

35 ctace Chemotherapy drug + Lipiodol Selective retained within the tumor Raising the exposure of neoplastic cell to chemotherapy Hepatic artery is occluded

36 ctace ctace Chemotherapy Drug Lipiodol Embolization +

37 Lipiodol Ethiodized or iodized oil (Lipiodol, Guerbet) Iodinated ester derived from poppy seed oil

38 TACE Selectively deliver therapeutic agents to the arterial supply of a tumor Increased concentration of the chemotherapy reaches the tumor To achieve complete tumor necrosis while minimising ischemia to the surrounding liver parenchyma

39

40

41 Performing TACE Catheterization into the most distal portion Lipiodol + drug injection with slight force until overflowing into the portal vein in the embolized area Gelatin sponge slurry injection to completely obstruct the tumor feeding branch

42 Indication Intermediate-stage HCC; Large Multinodular HCC Pre-transplant setting Early HCC in patients unsuitable to curative therapy

43 Contraindication Decompensated cirrhosis Child-Pugh B8 Total bilirubin > 3 Extensive tumor with massive replacement of both entire lobe Severely reduced portal vein flow Main portal vein thrombosis Reverse flow Extrahepatic metastasis

44 Patient preparation NPO 6-8 hr IV fluid LEFT side Clean and shave perineum Foley catheter Inform consent

45 Patient preparation CBC plt PLT > 50, ,000 Coagulation INR < 1.5 LFT TB<3 BUN, Cr

46

47 Type a quote here. Johnny Appleseed

48

49

50

51

52

53

54

55

56 Gelfoam slurry

57 Post-procedure care Bed rest Observe bleeding / hematoma / pulse Post-embolization syndrome Pain / NV / fever / leukocytosis Medical treatment

58 End-point Complete necrosis / no viable HCC Progression of disease No response after 2 sessions Metastasis Contraindication for TACE Child-Pugh / LFT

59 Result: HCC Barcelona-Clinic Liver Cancer Group J Hepatology 2003;37: Meta-analysis Results-2 year Survival TREATED 41% [19-63%] UNTREATED 27% [11-50%]

60 Result: HCC CR rate = % 5-year survival rate 26% Matui O, et al. J Hepatobiliary Pancreat Sci 17:407-9, 2010

61 Result: HCC OS = 3.3 years 5-year survival = 34% Takayasu, et al. J Hepatology; 2012

62 Cholangiocarcinoma

63 Interventional Radiologist Diagnosis US / CT FNA / Biopsy Treatment PTBD Preoperative Palliative

64 Diagnosis: CT scan

65 Diagnosis: CT scan

66 Aspiration for cytology

67 Core needle biopsy

68 PTBD

69 PTBD Percutaneous biliary drainage External drainage

70 Indication Biliary obstruction Malignancy Stricture Cholangitis or infected bile Bile duct injury or bile leak

71 Contraindication Uncorrectable coagulopathy Multisegmental obstruction Massive ascites

72

73

74

75

76 Catheter care Dressing every 3 days at home or hospital Exchange PTBD every 3 months Irrigate / check when Bile leak Decreased about of bile Increased jaundice Ascites leak

Hepatocellular Carcinoma: Diagnosis and Management

Hepatocellular Carcinoma: Diagnosis and Management Hepatocellular Carcinoma: Diagnosis and Management Nizar A. Mukhtar, MD Co-director, SMC Liver Tumor Board April 30, 2016 1 Objectives Review screening/surveillance guidelines Discuss diagnostic algorithm

More information

Locoregional Therapy for Hepatoma

Locoregional Therapy for Hepatoma Locoregional Therapy for Hepatoma Robert D. Crane, MD Interventional Radiology Virginia Mason How do we know a liver mass is HCC? HCC : Bx Of pts getting liver transplant only ~ 5% had Bx to establish

More information

Staging & Current treatment of HCC

Staging & Current treatment of HCC Staging & Current treatment of HCC Dr.: Adel El Badrawy Badrawy; ; M.D. Staging & Current ttt of HCC Early stage HCC is typically silent. HCC is often advanced at first manifestation. The selective ttt

More information

Hepatocellular Carcinoma: A major global health problem. David L. Wood, MD Interventional Radiology Banner Good Samaritan Medical Center

Hepatocellular Carcinoma: A major global health problem. David L. Wood, MD Interventional Radiology Banner Good Samaritan Medical Center Hepatocellular Carcinoma: A major global health problem David L. Wood, MD Interventional Radiology Banner Good Samaritan Medical Center Hepatocellular Carcinoma WORLDWIDE The #2 Cancer Killer Overall cancer

More information

Hepatobiliary Malignancies Retrospective Study at Truman Medical Center

Hepatobiliary Malignancies Retrospective Study at Truman Medical Center Hepatobiliary Malignancies 206-207 Retrospective Study at Truman Medical Center Brandon Weckbaugh MD, Prarthana Patel & Sheshadri Madhusudhana MD Introduction: Hepatobiliary malignancies are cancers which

More information

Locoregional Treatments for HCC Applications in Transplant Candidates. Locoregional Treatments for HCC Applications in Transplant Candidates

Locoregional Treatments for HCC Applications in Transplant Candidates. Locoregional Treatments for HCC Applications in Transplant Candidates Locoregional Treatments for HCC Applications in Transplant Candidates Matthew Casey, MD March 31, 2016 Locoregional Treatments for HCC Applications in Transplant Candidates *No disclosures *Off-label uses

More information

Hepatocellular Carcinoma HCC Updated November 2015 by: Dr. Mohammed Alghamdi (Medical Oncology Fellow, University of Calgary)

Hepatocellular Carcinoma HCC Updated November 2015 by: Dr. Mohammed Alghamdi (Medical Oncology Fellow, University of Calgary) Hepatocellular Carcinoma HCC Updated November 2015 by: Dr. Mohammed Alghamdi (Medical Oncology Fellow, University of Calgary) Staff Reviewers: Dr. Yoo Joung Ko (Medical Oncologist, Sunnybrook Odette Cancer

More information

Surveillance for Hepatocellular Carcinoma

Surveillance for Hepatocellular Carcinoma Surveillance for Hepatocellular Carcinoma Marion G. Peters, MD John V. Carbone, MD, Endowed Chair Professor of Medicine Chief of Hepatology Research University of California San Francisco Recorded on April

More information

Management of Colorectal Liver Metastases

Management of Colorectal Liver Metastases Management of Colorectal Liver Metastases MM Bernon, JEJ Krige HPB Surgical Unit, Groote Schuur Hospital Department of Surgery, University of Cape Town 50% of patients with colorectal cancer develop liver

More information

Liver Cancer: Diagnosis and Treatment Options

Liver Cancer: Diagnosis and Treatment Options Liver Cancer: Diagnosis and Treatment Options Fred Poordad, MD Chief, Hepatology University Transplant Center Professor of Medicine UT Health, San Antonio VP, Academic and Clinical Affairs, Texas Liver

More information

Tumor incidence varies significantly, depending on geographical location.

Tumor incidence varies significantly, depending on geographical location. Hepatocellular carcinoma is the 5 th most common malignancy worldwide with male-to-female ratio 5:1 in Asia 2:1 in the United States Tumor incidence varies significantly, depending on geographical location.

More information

WHAT IS THE BEST APPROACH FOR TRANS-ARTERIAL THERAPY IN HCC?

WHAT IS THE BEST APPROACH FOR TRANS-ARTERIAL THERAPY IN HCC? WHAT IS THE BEST APPROACH FOR TRANS-ARTERIAL THERAPY IN HCC? Dr. Alexander Kim Chief, Vascular and Interventional Radiology, Medstar Georgetown University Hospital, USA DISCLAIMER Please note: The views

More information

MULTI-DISCIPLINARY MANAGEMENT OF INTERMEDIATE STAGE HCC

MULTI-DISCIPLINARY MANAGEMENT OF INTERMEDIATE STAGE HCC Dr Apoorva Gogna MBBS FRCR FAMS Consultant Interventional Radiology Center Department of Diagnostic Radiology SingaporeGeneral Hospital MULTI-DISCIPLINARY MANAGEMENT OF INTERMEDIATE STAGE HCC CASE HISTORY

More information

Treatment of Hepatocellular Carcinoma. Andrew J. Muir, MD MHS Division of Gastroenterology Duke University Medical Center

Treatment of Hepatocellular Carcinoma. Andrew J. Muir, MD MHS Division of Gastroenterology Duke University Medical Center Treatment of Hepatocellular Carcinoma Andrew J. Muir, MD MHS Division of Gastroenterology Duke University Medical Center Epidemiology of HCC: world The 5 th most common cancer worldwide > 500, 000 new

More information

TRANSEARTERIAL CHEMO- EMBOLIZATION FOR HEPATIC METASTASES FROM NEURO-ENDOCINE NEOPLASIA AND HEPATOMA DR SAMIA AHMAD

TRANSEARTERIAL CHEMO- EMBOLIZATION FOR HEPATIC METASTASES FROM NEURO-ENDOCINE NEOPLASIA AND HEPATOMA DR SAMIA AHMAD UNIVERSITY OF PRETORIA STEVE BIKO ACADEMIC HOSPITAL SOUTH AFRICA TRANSEARTERIAL CHEMO- EMBOLIZATION FOR HEPATIC METASTASES FROM NEURO-ENDOCINE NEOPLASIA AND HEPATOMA DR SAMIA AHMAD 1 INTRODUCTION Hepatic

More information

Ruolo della interventistica per le secondarietà epatiche e di altre sedi

Ruolo della interventistica per le secondarietà epatiche e di altre sedi Ruolo della interventistica per le secondarietà epatiche e di altre sedi Giancarlo Bizzarri Dipartimento di Diagnostica per Immagini e Radiologia Interventistica Ospedale Regina Apostolorum, Albano Laziale

More information

HCC Imaging and Advances in Locoregional Therapy. David S. Kirsch MD Ochsner Clinic Foundation

HCC Imaging and Advances in Locoregional Therapy. David S. Kirsch MD Ochsner Clinic Foundation HCC Imaging and Advances in Locoregional Therapy David S. Kirsch MD Ochsner Clinic Foundation -Nothing to disclose Hepatic Imaging Primary imaging modalities include: US CT MR Angiography Nuclear medicine

More information

Liver Tumors. Prof. Dr. Ahmed El - Samongy

Liver Tumors. Prof. Dr. Ahmed El - Samongy Liver Tumors Prof. Dr. Ahmed El - Samongy Objective 1. Identify the most important features of common benign liver tumors 2. Know the risk factors, diagnosis, and management of hepatocellular carcinoma

More information

Regional Therapy for Metastatic Neuroendocrine Tumors. Janette Durham, MD Professor of Radiology University of Colorado School of Medicine

Regional Therapy for Metastatic Neuroendocrine Tumors. Janette Durham, MD Professor of Radiology University of Colorado School of Medicine Regional Therapy for Metastatic Neuroendocrine Tumors Janette Durham, MD Professor of Radiology University of Colorado School of Medicine Introduce regional therapy for mnet Arterial therapies Injection

More information

A) PUBLIC HEALTH B) PRESENTATION & DIAGNOSIS

A) PUBLIC HEALTH B) PRESENTATION & DIAGNOSIS Hepatocellular Carcinoma HCC Updated November 2015 by: Dr. Mohammed Alghamdi (Medical Oncology Fellow, University of Calgary), April 2017 by Dr. Jenny Ko (Medical Oncologist, Abbotsford Centre, BC Cancer

More information

Liver Directed Therapy for Hepatocellular Carcinoma

Liver Directed Therapy for Hepatocellular Carcinoma Liver Directed Therapy for Hepatocellular Carcinoma Anil K Pillai MD, FRCR, Associate Professor, Department of Radiology UT Houston Health Science Center, Houston, TX, United States. Hepatocellular cancer

More information

Celsion Symposium New Paradigms in HCC Staging: HKLC vs. BCLC Staging

Celsion Symposium New Paradigms in HCC Staging: HKLC vs. BCLC Staging Celsion Symposium New Paradigms in HCC Staging: HKLC vs. BCLC Staging Ronnie T.P. Poon, MBBS, MS, PhD Chair Professor of Hepatobiliary and Pancreatic Surgery Chief of Hepatobiliary and Pancreatic Surgery

More information

Radioembolization with Lipiodol for the Treatment of Hepatocellular Carcinoma and Liver Metastases

Radioembolization with Lipiodol for the Treatment of Hepatocellular Carcinoma and Liver Metastases Radioembolization with Lipiodol for the Treatment of Hepatocellular Carcinoma and Liver Metastases Pr Francesco Giammarile CHLS Lyon Faculté de Lyon Sud «Aut tace aut loquere meliora silentio» Malignant

More information

Liver Tumors. Patient Education. Treatment options 8 4A. About the Liver. Surgical Specialties

Liver Tumors. Patient Education. Treatment options 8 4A. About the Liver. Surgical Specialties Patient Education Treatment options This handout describes different kinds of tumors that form in the liver and how they are treated. About the Liver Your liver is the largest organ in your abdomen. It

More information

Imaging of liver and pancreas

Imaging of liver and pancreas Imaging of liver and pancreas.. Disease of the liver Focal liver disease Diffusion liver disease Focal liver disease Benign Cyst Abscess Hemangioma FNH Hepatic adenoma HCC Malignant Fibrolamellar carcinoma

More information

EASL-EORTC Guidelines

EASL-EORTC Guidelines Pamplona, junio de 2008 CLINICAL PRACTICE GUIDELINES: PARADIGMS IN MANAGEMENT OF HCC EASL-EORTC Guidelines Bruno Sangro Clínica Universidad de Navarra. CIBERehd. Pamplona, Spain Levels of Evidence according

More information

TACE: coming of age?

TACE: coming of age? Invasive procedures in the diagnosis and treatment of liver diseases: focal lesions F.Farinati Gastroenterologia, Padova TACE: coming of age? AISF 2005 TACE: LEVELS OF EVIDENCE Degree of certainty Methodology

More information

Hepatocellular Carcinoma. Markus Heim Basel

Hepatocellular Carcinoma. Markus Heim Basel Hepatocellular Carcinoma Markus Heim Basel Outline 1. Epidemiology 2. Surveillance 3. (Diagnosis) 4. Staging 5. Treatment Epidemiology of HCC Worldwide, liver cancer is the sixth most common cancer (749

More information

The Egyptian Journal of Hospital Medicine (October 2017) Vol.69(1), Page

The Egyptian Journal of Hospital Medicine (October 2017) Vol.69(1), Page The Egyptian Journal of Hospital Medicine (October 2017) Vol.69(1), Page 1674-1679 Radioembolization in Treatment of Hepatocellular Carcinoma with Portal Vein Invasion Elsahhar Ahmed Hetta, Osama Mohamed

More information

Disclosure. Speaker name: Prof. Maciej Pech I have the following potential conflicts of interest to report:

Disclosure. Speaker name: Prof. Maciej Pech I have the following potential conflicts of interest to report: Disclosure Speaker name: Prof. Maciej Pech I have the following potential conflicts of interest to report: Consulting Employment in industry Stockholder of a healthcare company Owner of a healthcare company

More information

Hepatocellular Carcinoma (HCC): Who Should be Screened and How Do We Treat? Tom Vorpahl MSN, RN, ACNP-BC

Hepatocellular Carcinoma (HCC): Who Should be Screened and How Do We Treat? Tom Vorpahl MSN, RN, ACNP-BC Hepatocellular Carcinoma (HCC): Who Should be Screened and How Do We Treat? Tom Vorpahl MSN, RN, ACNP-BC Objectives Identify patient risk factors for hepatocellular carcinoma (HCC) Describe strategies

More information

UPDATE TO THE MANAGEMENT OF PATIENTS WITH HCC HCA

UPDATE TO THE MANAGEMENT OF PATIENTS WITH HCC HCA UPDATE TO THE MANAGEMENT OF PATIENTS WITH HCC HUSSEIN K. MOHAMED MD, FACS. Transplant and Hepato-biliary Surgery Largo Medical Center HCA DISCLOSURE I have no financial relationship(s) relevant to the

More information

TREATMENT FOR HCC AND CHOLANGIOCARCINOMA. Shawn Pelletier, MD

TREATMENT FOR HCC AND CHOLANGIOCARCINOMA. Shawn Pelletier, MD TREATMENT FOR HCC AND CHOLANGIOCARCINOMA Shawn Pelletier, MD Treatment for HCC Treatment strategies Curative first line therapy Thermal ablation vs Resection vs Transplant Other first line therapies TACE

More information

Interventional Radiologic Treatment of Hepatocellular Carcinoma

Interventional Radiologic Treatment of Hepatocellular Carcinoma Interventional Radiologic Treatment of Hepatocellular Carcinoma Fatih Boyvat Abstract The current treatment modalities for patients with hepatocellular carcinoma are discussed in this review. Hepatocellular

More information

NAACCR Webinar Series 1

NAACCR Webinar Series 1 Collecting Cancer Data: Liver 2013 2014 NAACCR Webinar Series June 5, 2014 Q&A Please submit all questions concerning webinar content through the Q&A panel. Reminder: If you have participants watching

More information

Hepatocellular Carcinoma (HCC)

Hepatocellular Carcinoma (HCC) Title Slide Hepatocellular Carcinoma (HCC) Professor Muhammad Umar MBBS, MCPS, FCPS (PAK), FACG (USA), FRCP (L), FRCP (G), ASGE-M(USA), AGAF (USA) Chair & Professor of Medicine Rawalpindi Medical College

More information

RFA-based Combination Therapy 肝病研究中心, 肝臟科 林口長庚醫院, 長庚醫學大學 (CHANG GUNG MEMORIAL HOSPITAL, LINKUO) 林成俊 (CHEN-CHUN LIN)

RFA-based Combination Therapy 肝病研究中心, 肝臟科 林口長庚醫院, 長庚醫學大學 (CHANG GUNG MEMORIAL HOSPITAL, LINKUO) 林成俊 (CHEN-CHUN LIN) RFA-based Combination Therapy 肝病研究中心, 肝臟科 林口長庚醫院, 長庚醫學大學 (CHANG GUNG MEMORIAL HOSPITAL, LINKUO) 林成俊 (CHEN-CHUN LIN) CONTENTS Introduction RFA-based Combination Therapy Ethanol injection (PEI) Saline perfusion

More information

HEPATIC METASTASES. We can state 3 types of metastases depending on their treatment options:

HEPATIC METASTASES. We can state 3 types of metastases depending on their treatment options: HEPATIC METASTASES 1. Definition Metastasis means the spread of cancer. Cancerous cells can separate from the primary tumor and enter the bloodstream or the lymphatic system (the one that produces, stores,

More information

Cholangiocarcinoma (Bile Duct Cancer)

Cholangiocarcinoma (Bile Duct Cancer) Cholangiocarcinoma (Bile Duct Cancer) The Bile Duct System (Biliary Tract) A network of bile ducts (tubes) connects the liver and the gallbladder to the small intestine. This network begins in the liver

More information

Multiple Primary Quiz

Multiple Primary Quiz Multiple Primary Quiz Case 1 A 72 year old man was found to have a 12 mm solid lesion in the pancreatic tail by computed tomography carried out during a routine follow up study of this patient with adult

More information

Trans-arterial radioembolisation (TARE) of unresectable HCC using Y-90 microspheres: is it dangerous in case of portal vein thrombosis?

Trans-arterial radioembolisation (TARE) of unresectable HCC using Y-90 microspheres: is it dangerous in case of portal vein thrombosis? Trans-arterial radioembolisation (TARE) of unresectable HCC using Y-90 microspheres: is it dangerous in case of portal vein thrombosis? Poster No.: C-1634 Congress: ECR 2014 Type: Authors: Keywords: DOI:

More information

Advances in percutaneous ablation for hepatocellular carcinoma

Advances in percutaneous ablation for hepatocellular carcinoma Advances in percutaneous ablation for hepatocellular carcinoma P. Nahon1,2,3 1 Hepatology, Jean Verdier Hospital, APHP, Bondy, France 2 Paris 13 university, Sorbonne Paris Cité, UFRSMBH, Bobigny, France

More information

RADIATION SEGMENTECTOMY. Robert J Lewandowski, MD

RADIATION SEGMENTECTOMY. Robert J Lewandowski, MD RADIATION SEGMENTECTOMY Robert J Lewandowski, MD Robert Lewandowski, M.D. Consultant/Advisory Board: Cook Medical, LLC, Arsenal, BTG International, Boston Scientific Corp., ABK Reference Unlabeled/Unapproved

More information

Liver 6/5/14. Collecting Cancer Data: Liver NAACCR Webinar Series. June 5, 2014

Liver 6/5/14. Collecting Cancer Data: Liver NAACCR Webinar Series. June 5, 2014 Collecting Cancer Data: Liver 2013 2014 NAACCR Webinar Series June 5, 2014 Q&A Please submit all questions concerning webinar content through the Q&A panel. Reminder: If you have participants watching

More information

Percutaneous ablation: indications, techniques and results

Percutaneous ablation: indications, techniques and results Percutaneous ablation: indications, techniques and results Giovan Giuseppe Di Costanzo Dipartimento dei Trapianti UOSC Epatologia AORN A Cardarelli - Napoli Treatment algorithm EASL, EORTC guidelines HCC

More information

Transarterial Chemoembolisation (TACE) with Drug-Eluting Beads

Transarterial Chemoembolisation (TACE) with Drug-Eluting Beads Transarterial Chemoembolisation (TACE) with Drug-Eluting Beads A minimally invasive treatment for liver cancer Provided as an educational service by Biocompatibles UK Ltd, a BTG International group company

More information

A Metastatic Adrenal Tumor from a Hepatocellular Carcinoma: Combination Therapy with Transarterial

A Metastatic Adrenal Tumor from a Hepatocellular Carcinoma: Combination Therapy with Transarterial A Metastatic Adrenal Tumor from a Hepatocellular Carcinoma: Combination Therapy with Transarterial Chemoembolization and Radiofrequency Ablation 1 Hyun-Jin Lim, M.D., Yun Ku Cho, M.D., Yong-Sik Ahn, M.D.,

More information

Liver Cancer And Tumours

Liver Cancer And Tumours Liver Cancer And Tumours What causes liver cancer? Many factors may play a role in the development of cancer. Because the liver filters blood from all parts of the body, cancer cells from elsewhere can

More information

Liver Cancer (Hepatocellular Carcinoma or HCC) Overview

Liver Cancer (Hepatocellular Carcinoma or HCC) Overview Liver Cancer (Hepatocellular Carcinoma or HCC) Overview Recent advances in liver cancer care seek to address the rising incidence of liver cancer, which has steadily increased over the past three decades.

More information

Liver resection for HCC

Liver resection for HCC 8 th LIVER INTEREST GROUP Annual Meeting Cape Town 2017 Liver resection for HCC Jose Ramos University of the Witwatersrand Donald Gordon Medical Centre The liver is almost unique in that treatment of the

More information

The Egyptian Journal of Hospital Medicine (April 2018) Vol. 71(1), Page

The Egyptian Journal of Hospital Medicine (April 2018) Vol. 71(1), Page The Egyptian Journal of Hospital Medicine (April 2018) Vol. 71(1), Page 2315-2321 Role of MRI in Assessment of Hepatocellular Carcinoma (HCC) after TACE (Trans-arterial Chemoembolization) with Persistent

More information

CHEMOEMBOLISATION USING IODIZED OIL(LIPIODOL ) BASED TECHNIQUES

CHEMOEMBOLISATION USING IODIZED OIL(LIPIODOL ) BASED TECHNIQUES CHEMOEMBOLISATION USING IODIZED OIL(LIPIODOL ) BASED TECHNIQUES Peter Huppert Department of Radiology, Neuroradiology and Nuclear Medicine Klinikum Darmstadt ATH Universities of Frankfurt and Heidelberg/Mannhein

More information

In- and exclusion criteria

In- and exclusion criteria In- and exclusion criteria Kerstin Schütte Department of Gastroenterology, Hepatology and Infectious Diseases University of Magdeburg Overview: Study population Inclusion criteria I - General criteria

More information

LIVER SURGERY 2. Case 1. Med 5 Refresher Course (Surgery) 2013/14. Dr Sunny Cheung

LIVER SURGERY 2. Case 1. Med 5 Refresher Course (Surgery) 2013/14. Dr Sunny Cheung LIVER SURGERY 2 Med 5 Refresher Course (Surgery) 2013/14 24 Jun 2013 Dr Sunny Cheung Case 1 50/M Sudden onset of epigastric pain Abdominal distension Confused HR 120 BP 80/50 Haemocue = 8 What should you

More information

treatment options for primary liver malignancies and metastatic disease

treatment options for primary liver malignancies and metastatic disease State of the art treatment options for primary liver malignancies and metastatic disease Peter Huppert Prof. of Radiology and Neuroradiology Klinikum Darmstadt Certified Vascular and Oncologic Center Disclosure

More information

Primary Hepatic Neoplasms. estimated 560,000 new cases per year. There is tremendous regional variation in incidence of

Primary Hepatic Neoplasms. estimated 560,000 new cases per year. There is tremendous regional variation in incidence of Primary Hepatic Neoplasms Hepatocellular Carcinoma Incidence and Epidemiology Worldwide, hepatocellular carcinoma is the 3 rd most common causes of cancer death with an estimated 560,000 new cases per

More information

Liver transplantation: Hepatocellular carcinoma

Liver transplantation: Hepatocellular carcinoma Liver transplantation: Hepatocellular carcinoma Alejandro Forner BCLC Group. Liver Unit. Hospital Clínic. University of Barcelona 18 de marzo 2015 3r Curso Práctico de Transplante de Órganos Sólidos Barcelona

More information

Case Studies of Laser Ablation for Liver Tumors

Case Studies of Laser Ablation for Liver Tumors Case Studies of Laser Ablation for Liver Tumors Dr Giovan Giuseppe Di Costanzo, Head Physician, Department of Liver Pathophysiology - Cardarelli Hospital, Naples Case 1: HCC near vascular structures A

More information

ULTRA FLUID. Lipiodol efficacy & safety. for improved overall survival in HCC. Localization. Vectorization. Visualization. Chemo-Embolization

ULTRA FLUID. Lipiodol efficacy & safety. for improved overall survival in HCC. Localization. Vectorization. Visualization. Chemo-Embolization Ethyl ester of iodized fatty acids of poppy seed oil ULTRA FLUID Lipiodol efficacy & safety 1,2,3,4 for improved overall survival in HCC Localization Endorsed by International HCC Treatment Guidelines

More information

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE INTERVENTIONAL PROCEDURES PROGRAMME Interventional procedure overview of selective internal radiation therapy for primary liver cancer Selective internal

More information

Transcatheter hepatic arterial chemoembolization may be considered medically necessary to

Transcatheter hepatic arterial chemoembolization may be considered medically necessary to Original Issue Date (Created): July 1, 2002 Most Recent Review Date (Revised): September 24, 2013 Effective Date: November 1, 2013 I. POLICY Hepatocellular carcinoma Transcatheter hepatic arterial chemoembolization

More information

Hepatocellular carcinoma: Intra-arterial treatments

Hepatocellular carcinoma: Intra-arterial treatments Hepatocellular carcinoma: Intra-arterial treatments Irene Bargellini U.O. Radiologia Interventistica Azienda Ospedaliero Universitaria Pisana IRENE BARGELLINI,MD UO RADIOLOGIA INTERVENTISTICA, AZIENDA

More information

9th Paris Hepatitis Conference

9th Paris Hepatitis Conference 9th Paris Hepatitis Conference Paris, 12 January 2016 Treatment of hepatocellular carcinoma: beyond international guidelines Massimo Colombo Chairman Department of Liver, Kidney, Lung and Bone Marrow Units

More information

LiverGroup.org. Case Report Form (CRF) for STAGED procedures

LiverGroup.org. Case Report Form (CRF) for STAGED procedures Case Report Form (CRF) for STAGED procedures Patient Characteristics Case number * Age * ( 18)y Gender * Male Female Race * Caucasian Asian African Other If other race, please specify Height * cm Weight

More information

Unmet needs in intermediate HCC. Korea University Guro Hospital Ji Hoon Kim

Unmet needs in intermediate HCC. Korea University Guro Hospital Ji Hoon Kim Unmet needs in intermediate HCC Korea University Guro Hospital Ji Hoon Kim BCLC HCC Stage 0 PST 0, Child Pugh A Stage A C PST 0 2, Child Pugh A B Stage D PST > 2, Child Pugh C Very early stage (0) 1 HCC

More information

Paul Martin MD FACG. University of Miami

Paul Martin MD FACG. University of Miami Paul Martin MD FACG University of Miami 1 Liver cirrhosis of any cause Chronic C o c hepatitis epat t s B Risk increases with Male gender Age Diabetes Smoking ~5% increase in HCV-related HCC between 1991-28

More information

PEER-REVIEW REPORT CLASSIFICATION LANGUAGE EVALUATION SCIENTIFIC MISCONDUCT CONCLUSION. [ Y] Accept [ ] Grade B: Very good

PEER-REVIEW REPORT CLASSIFICATION LANGUAGE EVALUATION SCIENTIFIC MISCONDUCT CONCLUSION. [ Y] Accept [ ] Grade B: Very good Reviewer s code: 03656588 Reviewer s country: China Date reviewed: 2017-06-08 [ ] Grade A: Excellent [ Y] Accept [ ] Grade B: Very good [ ] High priority for [ Y] Grade C: Good language [ ] Major revision

More information

Radiofrequency Ablation of Liver Tumors

Radiofrequency Ablation of Liver Tumors Radiofrequency Ablation of Liver Tumors Michael M. Awad, Michael A. Choti Indications and Contraindications Indications Unresectable malignant tumors of the liver (e.g., hepatocellular carcinoma, colorectal

More information

Management of Liver Metastasis from Colorectal Carcinoma. Aisha White, M.D. SUNY Downstate Division of Transplantation

Management of Liver Metastasis from Colorectal Carcinoma. Aisha White, M.D. SUNY Downstate Division of Transplantation Management of Liver Metastasis from Colorectal Carcinoma Aisha White, M.D. SUNY Downstate Division of Transplantation Management of Colorectal Liver Metastasis Epidemiology 25% of patients diagnosed

More information

Bronchobiliary fistula treated with histoacryl embolization under bronchoscopic guidance: A case report

Bronchobiliary fistula treated with histoacryl embolization under bronchoscopic guidance: A case report Respiratory Medicine CME (2008) 1, 164 168 respiratory MEDICINE CME CASE REPORT Bronchobiliary fistula treated with histoacryl embolization under bronchoscopic guidance: A case report Jung Hyun Kim a,

More information

Hepatocellular carcinoma: from guidelines to individualized treatment

Hepatocellular carcinoma: from guidelines to individualized treatment AISF 2012 Rome, 22-24 February 2012 Hepatocellular carcinoma: from guidelines to individualized treatment A.D. 1088 Luigi Bolondi Professor of Medicine, Chairman Department of Digestive Diseases and Internal

More information

Analysis of efficacy and safety of TACE in combination with RFA and MWA in the treatment of middle and large primary hepatic carcinoma

Analysis of efficacy and safety of TACE in combination with RFA and MWA in the treatment of middle and large primary hepatic carcinoma JBUON 2019; 24(1): 163-170 ISSN: 1107-0625, online ISSN: 2241-6293 www.jbuon.com E-mail: editorial_office@jbuon.com ORIGINAL ARTICLE Analysis of efficacy and safety of TACE in combination with RFA and

More information

Liver Transplantation

Liver Transplantation 1 Liver Transplantation Department of Surgery Yonsei University Wonju College of Medicine Kim Myoung Soo M.D. ysms91@wonju.yonsei.ac.kr http://gs.yonsei.ac.kr History Development of Liver transplantation

More information

HCC: Is it an oncological disease? - No

HCC: Is it an oncological disease? - No June 13-15, 2013 Berlin, Germany Prof. Oren Shibolet Head of the Liver Unit, Department of Gastroenterology Tel-Aviv Sourasky Medical Center and Tel-Aviv University HCC: Is it an oncological disease? -

More information

Learning Objectives. After attending this presentation, participants will be able to:

Learning Objectives. After attending this presentation, participants will be able to: Learning Objectives After attending this presentation, participants will be able to: Describe HCV in 2015 Describe how to diagnose advanced liver disease and cirrhosis Identify the clinical presentation

More information

Study Objective and Design

Study Objective and Design Randomized, Open Label, Multicenter, Phase II Trial of Transcatheter Arterial Chemoembolization (TACE) Therapy in Combination with Sorafenib as Compared With TACE Alone in Patients with Hepatocellular

More information

6/16/2016. Treating Hepatocellular Carcinoma: Deciphering the Clinical Data. Liver Regeneration. Liver Regeneration

6/16/2016. Treating Hepatocellular Carcinoma: Deciphering the Clinical Data. Liver Regeneration. Liver Regeneration Treating : Deciphering the Clinical Data Derek DuBay, MD Associate Professor of Surgery Director of Liver Transplant Liver Transplant and Hepatobiliary Surgery UAB Department of Surgery Liver Regeneration

More information

Liver Perfusion Analysis New Frontiers in Dynamic Volume Imaging. Case Study Brochure Chang Gung Memorial Hospital.

Liver Perfusion Analysis New Frontiers in Dynamic Volume Imaging. Case Study Brochure Chang Gung Memorial Hospital. New Frontiers in Dynamic Volume Imaging dynamic volume CT Case Study Brochure Chang Gung Memorial Hospital http://www.toshibamedicalsystems.com Toshiba Medical Systems Corporation 2010-2011. All rights

More information

Imaging Guided Biopsy. Edited & Presented by ; Hussien A.B ALI DINAR. Msc Lecturer,Reporting Sonographer

Imaging Guided Biopsy. Edited & Presented by ; Hussien A.B ALI DINAR. Msc Lecturer,Reporting Sonographer Imaging Guided Biopsy Edited & Presented by ; Hussien A.B ALI DINAR. Msc Lecturer,Reporting Sonographer Objective By the End of this lessons you should : Define what biopsy Justify Aim to perform biopsy

More information

Management of HepatoCellular Carcinoma

Management of HepatoCellular Carcinoma 9th Symposium GIC St Louis - 2010 Management of HepatoCellular Carcinoma Overview Pierre A. Clavien, MD, PhD Department of Surgery University Hospital Zurich Zurich, Switzerland Hepatocellular carcinoma

More information

AllinaHealthSystems 1

AllinaHealthSystems 1 Disclosure I have no financial relationships to disclose. Dimensions in Oncology 2017 Liver Cancers Jill May, BSN, RN, OCN Hepatobiliary Cancer Care Coordinator 1 LIVER ~ Where and what is it? Located

More information

Radiofrequency Ablation versus Microwave Ablation in HCC and Liver Metastases

Radiofrequency Ablation versus Microwave Ablation in HCC and Liver Metastases Radiofrequency Ablation versus Microwave Ablation in HCC and Liver Metastases Thomas J. Vogl, B. Panahi, N. Nour-Eldin I D I R: Institute of Diagnostic and Interventional Radiology Goethe University Frankfurt,

More information

Combination therapy of TACE and PEI, TACE and RFA, and PEI and RFA for treatment of HCC

Combination therapy of TACE and PEI, TACE and RFA, and PEI and RFA for treatment of HCC Combination therapy of TACE and PEI, TACE and RFA, and PEI and RFA for treatment of HCC Poster No.: C-0747 Congress: ECR 2014 Type: Authors: Keywords: DOI: Educational Exhibit S. W. Jeon, J. H. Kwon, M.

More information

Percutaneous Ultrasound-guided Radiofrequency Ablation of Colorectal Liver Metastases

Percutaneous Ultrasound-guided Radiofrequency Ablation of Colorectal Liver Metastases Chin J Radiol 2005; 30: 153-158 153 Percutaneous Ultrasound-guided Radiofrequency Ablation of Colorectal Liver Metastases YI-YOU CHIOU YI-HONG CHOU JEN-HUEY CHIANG HSIN-KAI WANG CHENG-YEN CHANG Department

More information

LIVER IMAGING TIPS IN VARIOUS MODALITIES. M.Vlychou, MD, PhD Assoc. Professor of Radiology University of Thessaly

LIVER IMAGING TIPS IN VARIOUS MODALITIES. M.Vlychou, MD, PhD Assoc. Professor of Radiology University of Thessaly LIVER IMAGING TIPS IN VARIOUS MODALITIES M.Vlychou, MD, PhD Assoc. Professor of Radiology University of Thessaly Hepatocellular carcinoma is a common malignancy for which prevention, screening, diagnosis,

More information

Transcatheter Arterial Chemoembolization to Treat Primary or Metastatic Liver Malignancies

Transcatheter Arterial Chemoembolization to Treat Primary or Metastatic Liver Malignancies Transcatheter Arterial Chemoembolization to Treat Primary or Metastatic Liver Malignancies Policy Number: 8.01.11 Last Review: 6/2018 Origination: 8/2005 Next Review: 6/2019 Policy Blue Cross and Blue

More information

Index. Note: Page numbers of article titles are in boldface type.

Index. Note: Page numbers of article titles are in boldface type. Index Note: Page numbers of article titles are in boldface type. A ACLF. See Acute-on-chronic liver failure (ACLF) Acute kidney injury (AKI) in ACLF patients, 967 Acute liver failure (ALF), 957 964 causes

More information

Hepatocellular Carcinoma

Hepatocellular Carcinoma Hepatocellular Carcinoma Luis S. Marsano, MD Professor of Medicine Division of Gastroenterology, Hepatology, & Nutrition University of Louisville & Louisville VAMC 2010 Magnitude of the Problem 95% of

More information

Hepatocellular carcinoma in Sri Lanka - where do we stand?

Hepatocellular carcinoma in Sri Lanka - where do we stand? SCIENTIFIC ARTICLE Hepatocellular carcinoma in Sri Lanka - where do we stand? R.C. Siriwardana 1, C.A.H. Liyanage 1, M.B. Gunethileke 2 1. Specialist Gastrointestinal and Hepatobilliary Surgeon, Senior

More information

Are we adequately screening at-risk patients for hepatocellular carcinoma in the outpatient setting?

Are we adequately screening at-risk patients for hepatocellular carcinoma in the outpatient setting? Rajani Sharma, PGY1 Geriatrics CRC Project, 12/19/13 Are we adequately screening at-risk patients for hepatocellular carcinoma in the outpatient setting? A. Study Purpose and Rationale Hepatocellular carcinoma

More information

Hepato-Pancreatico-Biliary Surgery. Dr. Ankur J. Shah. MS, DNB, MNAMS, MRCSEd (UK), FRCS (UK)

Hepato-Pancreatico-Biliary Surgery. Dr. Ankur J. Shah. MS, DNB, MNAMS, MRCSEd (UK), FRCS (UK) Hepato-Pancreatico-Biliary Surgery Dr. Ankur J. Shah MS, DNB, MNAMS, MRCSEd (UK), FRCS (UK) Consultant Hepato-Pancreatico-Biliary and Liver Transplant Surgeon Ansh Liver Clinic Prevention to Cure Address

More information

doi: /hepr Response Evaluation Criteria in Cancer of the Liver (RECICL) (2015 Revised version)

doi: /hepr Response Evaluation Criteria in Cancer of the Liver (RECICL) (2015 Revised version) bs_bs_banner Hepatology Research 2016; 46: 3 9 doi: 10.1111/hepr.12542 Special Report Response Evaluation Criteria in Cancer of the Liver (RECICL) (2015 Revised version) Masatoshi Kudo, Kazuomi Ueshima,

More information

Elaine A. Leigh DNP, FNP-BC Mercy Health Hepatitis C Clinic Hackley Campus / Fax

Elaine A. Leigh DNP, FNP-BC Mercy Health Hepatitis C Clinic Hackley Campus / Fax Elaine A. Leigh DNP, FNP-BC Mercy Health Hepatitis C Clinic Hackley Campus 231-727-5575/231-728-4054 Fax » CURABLE» Most common blood borne infection» 75-85% of those exposed will develop chronic infection»

More information

Resection leads to cure in selected patients with hepatocellular

Resection leads to cure in selected patients with hepatocellular Overview: Where Does Radiation Therapy Fit in the Spectrum of Liver Cancer Local-Regional Therapies? Laura A. Dawson, MD*, Experience with radiation therapy for the treatment of hepatocellular carcinoma

More information

간암의조직검사 : 언제, 어떻게? 계명대학교의과대학내과학교실 정우진

간암의조직검사 : 언제, 어떻게? 계명대학교의과대학내과학교실 정우진 간암의조직검사 : 언제, 어떻게? 계명대학교의과대학내과학교실 정우진 간생검한다 vs 안한다? M/81 Alcoholic LC, albumin 4.0, bil 0.6, Cr 1.06, glucose 141, afp 2.2, CA19-9 12.41 CT: R/O HCC in S8, R/O CC M/69 HBV(-), HCV(-), social alcoholics

More information

Interventional radiology

Interventional radiology Interventional radiology Nonvascular Doros Attila MD, Semmelweis Univ. Dept.of Transplantation and Surgery Radiology med IR/MIT Attempted non surgical invasive therapy with good results (sometimes as good

More information

Ontario s Adult Referral and Listing Criteria for Liver Transplantation

Ontario s Adult Referral and Listing Criteria for Liver Transplantation Ontario s Adult Referral and Listing Criteria for Liver Transplantation Version 3.0 Trillium Gift of Life Network Ontario s Adult Referral & Listing Criteria for Liver Transplantation PATIENT REFERRAL

More information

IS THERE A DIFFERENCE IN LIVER CANCER RATES IN PATIENTS WHO RECEIVE TREATMENT FOR HEPATITIS?

IS THERE A DIFFERENCE IN LIVER CANCER RATES IN PATIENTS WHO RECEIVE TREATMENT FOR HEPATITIS? IS THERE A DIFFERENCE IN LIVER CANCER RATES IN PATIENTS WHO RECEIVE TREATMENT FOR HEPATITIS? Dr. Sammy Saab David Geffen School of Medicine, Los Angeles, USA April 2018 DISCLAIMER Please note: The views

More information

Corporate Medical Policy

Corporate Medical Policy Corporate Medical Policy Cryosurgical Ablation of Primary or Metastatic Liver Tumors File Name: Origination: Last CAP Review: Next CAP Review: Last Review: cryosurgical_ablation_of_primary_or_metastatic_liver_tumors

More information

SBRT and hypofractionated RT for HCC patients with varying degrees of hepatic impairment

SBRT and hypofractionated RT for HCC patients with varying degrees of hepatic impairment SBRT and hypofractionated RT for HCC patients with varying degrees of hepatic impairment Nima Nabavizadeh, MD Assistant Professor Division Leader Hematologic Malignancies Co-division Leader Gastrointestinal

More information